Your browser doesn't support javascript.
loading
Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors' perspective.
Kähler, Katharina C; Gutzmer, Ralf; Angela, Yenny; Livingstone, Elisabeth; Lodde, Georg; Meiss, Frank; Rafei-Shamsabadi, David A; Weyer-Fahlbusch, Sera S; Nashan, Dorothée; Loquai, Carmen; Hassel, Jessica C; Sachse, Michael M M; Maul, Lara V; Heinzerling, Lucie; Heppt, Markus V; Colapietro, Chiara; Rusch, Judith; Blome, Christine.
Afiliação
  • Kähler KC; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany. kckaehler@yahoo.de.
  • Gutzmer R; Department of Dermatology, Johannes Wesling Medical Center Minden, Ruhr University Bochum Medical School, Bochum, Germany.
  • Angela Y; Department of Dermatology, Johannes Wesling Medical Center Minden, Ruhr University Bochum Medical School, Bochum, Germany.
  • Livingstone E; Department of Dermatology, University Hospital Essen, Essen, Germany.
  • Lodde G; Department of Dermatology, University Hospital Essen, Essen, Germany.
  • Meiss F; Department of Dermatology, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany.
  • Rafei-Shamsabadi DA; Department of Dermatology, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany.
  • Weyer-Fahlbusch SS; Department of Dermatology, Dortmund, Germany.
  • Nashan D; Department of Dermatology, Dortmund, Germany.
  • Loquai C; Department of Dermatology, Klinikum Bremen-Ost, Gesundheitnord gGmbH, Bremen, Germany.
  • Hassel JC; Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), Heidelberg University, NCT Heidelberg, a partnership between DKFZ and University Hospital Heidelberg, Heidelberg, Germany.
  • Sachse MMM; Department of Dermatology, Bremerhaven, Germany.
  • Maul LV; Department of Dermatology, University Hospital Basel, Basel, Switzerland.
  • Heinzerling L; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Heppt MV; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
  • Colapietro C; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany.
  • Rusch J; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.
  • Blome C; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.
J Cancer Res Clin Oncol ; 150(5): 252, 2024 May 14.
Article em En | MEDLINE | ID: mdl-38743104
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Melanoma / Recidiva Local de Neoplasia Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Melanoma / Recidiva Local de Neoplasia Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article